Halozyme Therapeutics Inc. (RV7)
FSX
Closed
Sep 25, 2026
Day's Range
100.8552 wk Range
52.50Overview - RV7 - Halozyme Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
11.24B
P/E (Trailing)
‪33.88‬
P/E (Forward)
‪38.41‬
PEG Ratio
‪0.76‬
Price / Sales (TTM)
‪6.86‬
Price / Book
‪92.68‬
EV / EBITDA
‪12.28‬
Profitability
Gross Margin
‪83.54%‬
Profit Margin
‪24.85%‬
Operating Margin
‪59.80%‬
Return on Assets
‪25.49%‬
Return on Equity
‪173.67%‬
Ownership
Shares Outstanding
114.04M
Float
112.18M
Held by Insiders
‪1.10%‬
Held by Institutions
‪112.13%‬
Price stats
Beta
‪0.88‬
50-Day Avg
‪84.00‬
200-Day Avg
‪65.74‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - RV7 - Halozyme Therapeutics Inc.
Peers - RV7 - Halozyme Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on FSX.
- RV7FSXHalozyme Therapeutics Inc.11.15BMarket Cap+36.42%52-week change33.89P/E (Trailing)‪24.85%‬Profit Margin
- ANLFSXAnalog Devices Inc.179.11BMarket Cap+43.92%52-week change47.10P/E (Trailing)‪29.78%‬Profit Margin
- 0QFFSXModerna Inc.69.12BMarket Cap+87.76%52-week change25.27P/E (Trailing)‪-141.42%‬Profit Margin
- 64BFSXAstera Labs, Inc.53.43BMarket Cap+42.53%52-week change179.66P/E (Trailing)‪30.74%‬Profit Margin
- 1AEFSXargenx SE52.63BMarket Cap+28.29%52-week change36.62P/E (Trailing)‪32.26%‬Profit Margin
- 1AEAFSXargenx SE American Depositary Receipt50.36BMarket Cap+25.47%52-week change34.88P/E (Trailing)‪32.26%‬Profit Margin
- 42ZFSXRevolution Medicines, Inc.37.58BMarket Cap+78.78%52-week change-29.47P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - RV7 - Halozyme Therapeutics Inc.
About
Halozyme Therapeutics Inc. is a biopharmaceutical company that researches, develops, and commercializes proprietary enzymes and drug delivery technologies. Its core platform centers on the patented recombinant human hyaluronidase enzyme (rHuPH20), enabling subcutaneous administration of injectable biologics like…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
